144 related articles for article (PubMed ID: 9184854)
21. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
Bhuvarahamurthy V; Kristiansen GO; Johannsen M; Loening SA; Schnorr D; Jung K; Staack A
Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214
[TBL] [Abstract][Full Text] [Related]
22. Collagenolytic and gelatinolytic matrix metalloproteinases and their inhibitors in basal cell carcinoma of skin: comparison with normal skin.
Varani J; Hattori Y; Chi Y; Schmidt T; Perone P; Zeigler ME; Fader DJ; Johnson TM
Br J Cancer; 2000 Feb; 82(3):657-65. PubMed ID: 10682680
[TBL] [Abstract][Full Text] [Related]
23. Upregulation of matrix metalloproteinases in a model of T cell mediated tissue injury in the gut: analysis by gene array and in situ hybridisation.
Salmela MT; MacDonald TT; Black D; Irvine B; Zhuma T; Saarialho-Kere U; Pender SL
Gut; 2002 Oct; 51(4):540-7. PubMed ID: 12235077
[TBL] [Abstract][Full Text] [Related]
24. Collagenase-3 expression is associated with advanced local invasion in human squamous cell carcinomas of the larynx.
Cazorla M; Hernández L; Nadal A; Balbín M; López JM; Vizoso F; Fernández PL; Iwata K; Cardesa A; López-Otín C; Campo E
J Pathol; 1998 Oct; 186(2):144-50. PubMed ID: 9924429
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinase localisation by in situ-RT-PCR in archival human breast biopsy material.
Haupt LM; Irving RE; Weinstein SR; Irving MG; Griffiths LR
Mol Cell Probes; 2008 Apr; 22(2):83-9. PubMed ID: 17669621
[TBL] [Abstract][Full Text] [Related]
26. Detection and localization of mRNAs encoding matrix metalloproteinases and their tissue inhibitor in human breast pathology.
Polette M; Clavel C; Cockett M; Girod de Bentzmann S; Murphy G; Birembaut P
Invasion Metastasis; 1993; 13(1):31-7. PubMed ID: 8407209
[TBL] [Abstract][Full Text] [Related]
27. Role of the matrix metalloproteinase and tissue inhibitors of metalloproteinase families in noninvasive and invasive tumors transplanted in mice with severe combined immunodeficiency.
Furukawa A; Tsuji M; Nishitani M; Kanda K; Inoue Y; Kanayama H; Kagawa S
Urology; 1998 May; 51(5):849-53. PubMed ID: 9610608
[TBL] [Abstract][Full Text] [Related]
28. Enhanced expression of interstitial collagenase, stromelysin-1, and urokinase plasminogen activator in lesions of dermatitis herpetiformis.
Airola K; Vaalamo M; Reunala T; Saarialho-Kere UK
J Invest Dermatol; 1995 Aug; 105(2):184-9. PubMed ID: 7636299
[TBL] [Abstract][Full Text] [Related]
29. Basic calcium phosphate crystal induction of collagenase 1 and stromelysin expression is dependent on a p42/44 mitogen-activated protein kinase signal transduction pathway.
Brogley MA; Cruz M; Cheung HS
J Cell Physiol; 1999 Aug; 180(2):215-24. PubMed ID: 10395291
[TBL] [Abstract][Full Text] [Related]
30. Expression of stromelysin 3 in basal cell carcinomas.
Cribier B; Noacco G; Peltre B; Grosshans E
Eur J Dermatol; 2001; 11(6):530-3. PubMed ID: 11701402
[TBL] [Abstract][Full Text] [Related]
31. Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds.
Saarialho-Kere UK; Pentland AP; Birkedal-Hansen H; Parks WC; Welgus HG
J Clin Invest; 1994 Jul; 94(1):79-88. PubMed ID: 8040294
[TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo MMP gene expression localisation by In Situ-RT-PCR in cell culture and paraffin embedded human breast cancer cell line xenografts.
Haupt LM; Thompson EW; Trezise AE; Irving RE; Irving MG; Griffiths LR
BMC Cancer; 2006 Jan; 6():18. PubMed ID: 16430785
[TBL] [Abstract][Full Text] [Related]
33. The human collagenase-3 (CLG3) gene is located on chromosome 11q22.3 clustered to other members of the matrix metalloproteinase gene family.
Pendás AM; Matilla T; Estivill X; López-Otín C
Genomics; 1995 Apr; 26(3):615-8. PubMed ID: 7607691
[TBL] [Abstract][Full Text] [Related]
34. Role of tissue inhibitors of metalloproteinases (TIMPs) in colorectal carcinoma.
Joo YE; Seo KS; Kim J; Kim HS; Rew JS; Park CS; Kim SJ
J Korean Med Sci; 1999 Aug; 14(4):417-23. PubMed ID: 10485622
[TBL] [Abstract][Full Text] [Related]
35. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas.
Kossakowska AE; Urbanski SJ; Watson A; Hayden LJ; Edwards DR
Oncol Res; 1993; 5(1):19-28. PubMed ID: 8369572
[TBL] [Abstract][Full Text] [Related]
36. Increased expression of matrix metalloproteinase-3 (stromelysin-1) in cultured fibroblasts and basal cell carcinomas of nevoid basal cell carcinoma syndrome.
Majmudar G; Nelson BR; Jensen TC; Johnson TM
Mol Carcinog; 1994 Sep; 11(1):29-33. PubMed ID: 7916987
[TBL] [Abstract][Full Text] [Related]
37. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.
Nakada M; Nakamura H; Ikeda E; Fujimoto N; Yamashita J; Sato H; Seiki M; Okada Y
Am J Pathol; 1999 Feb; 154(2):417-28. PubMed ID: 10027400
[TBL] [Abstract][Full Text] [Related]
38. Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas.
Bolon I; Devouassoux M; Robert C; Moro D; Brambilla C; Brambilla E
Am J Pathol; 1997 May; 150(5):1619-29. PubMed ID: 9137088
[TBL] [Abstract][Full Text] [Related]
39. Matrix metalloproteinase-1 and -3 in breast cancer: correlation with progesterone receptors and other clinicopathologic features.
Nakopoulou L; Giannopoulou I; Gakiopoulou H; Liapis H; Tzonou A; Davaris PS
Hum Pathol; 1999 Apr; 30(4):436-42. PubMed ID: 10208466
[TBL] [Abstract][Full Text] [Related]
40. Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas.
Bolon I; Gouyer V; Devouassoux M; Vandenbunder B; Wernert N; Moro D; Brambilla C; Brambilla E
Am J Pathol; 1995 Nov; 147(5):1298-310. PubMed ID: 7485393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
